Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin

In the current study, the metabolic effects of atorvastatin dose escalation versus atorvastatin/fenofibric acid combination were compared using metabolomics analyses. Men and women with combined hyperlipidaemia were initially prescribed atorvastatin (10 mg, ≥4 weeks). Patients who reached low-densit...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ji Soo, Kim, Kyu, Jung, Youngae, Lee, Jae-Hwan, Namgung, June, Lee, Hae-Young, Suh, Jon, Hwang, Geum-Sook, Lee, Sang-Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168550/
https://www.ncbi.nlm.nih.gov/pubmed/30279504
http://dx.doi.org/10.1038/s41598-018-33058-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168550/
https://www.ncbi.nlm.nih.gov/pubmed/30279504
http://dx.doi.org/10.1038/s41598-018-33058-x

Ejemplares similares